Literature DB >> 17433313

Comparison of urinary and recombinant human chorionic gonadotropin during ovulation induction in intrauterine insemination cycles: a prospective randomized clinical trial.

Khaled Sakhel1, Mohamed Khedr, Sandra Schwark, Mohammad Ashraf, Michael H Fakih, Mostafa Abuzeid.   

Abstract

OBJECTIVES: To compare the in vivo effectiveness of recombinant (r) hCG with urinary (u) hCG during controlled ovarian hyperstimulation and intrauterine insemination (COH-IUI) cycles.
DESIGN: Prospective controlled clinical study.
SETTING: Private IVF center. PATIENT(S): Two hundred eighty-four subjects undergoing COH-IUI cycles. INTERVENTIONS(S): Women were randomized into receiving r-hCG or u-hCG for final maturation and induction of ovulation. MAIN OUTCOME MEASURE(S): Clinical pregnancy rate and outcome of pregnancy. RESULT(S): Background characteristics were similar in the two groups studied except for a slight difference in the mean duration of infertility (3.0 vs. 2.3). There was no significant difference in the number of follicles > or =16 mm, mean peak E(2), or mean 1-week P levels between the two groups. The clinical pregnancy rate was 27.1% in the recombinant group compared with 28.5% in the urinary group. The outcome of pregnancy was similar in both groups. CONCLUSION(S): Recombinant hCG was found to be as effective as u-hCG in achieving pregnancy during COH-IUI cycles. This is in agreement with earlier studies on the effectiveness of r-hCG in IVF cycles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433313     DOI: 10.1016/j.fertnstert.2006.11.025

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.

Authors:  Mohamed A Youssef; Ahmed M Abou-Setta; Wai Sun Lam
Journal:  Cochrane Database Syst Rev       Date:  2016-04-23

2.  A LC-MS All-in-One Workflow for Site-Specific Location, Identification and Quantification of N-/O- Glycosylation in Human Chorionic Gonadotropin Drug Products.

Authors:  Hongbin Zhu; Chen Qiu; Ashley C Ruth; David A Keire; Hongping Ye
Journal:  AAPS J       Date:  2017-02-28       Impact factor: 4.009

3.  Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Zahra Ezabadi; Fatemeh Hasani; Mohammad Chehrazi
Journal:  J Assist Reprod Genet       Date:  2012-12-29       Impact factor: 3.412

Review 4.  Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility.

Authors:  Astrid Ep Cantineau; Anouk Gh Rutten; Ben J Cohlen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-05

5.  A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle® for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation.

Authors:  Abha Majumdar; Rekha Sachan; Yogeshwar S Nandanwar; Rahul V Mayekar; Neelu Soni; Manish R Banker; Rajan S Vaidya; Manjeet Arora; Girish P Godbole; Gautam V Daftary; Ganesh H Divekar; James John
Journal:  J Hum Reprod Sci       Date:  2019 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.